Marisa Miceli, MD

Associate Professor
University of Michigan
Ann Arbor, Michigan, United States

SCYNEXIS, Inc. (Advisor or Review Panel member)

Presentation(s):

• 120 - An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis

  On Demand

• 123 - Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)

  On Demand